Asarina Pharma Investor Relations Material
Latest events
Q4 2023
27 Feb, 2024
Q2 2023
23 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Asarina Pharma
Access all reports
Asarina Pharma is a Swedish biopharmaceutical company focused on the development of treatments for neurological and hormonal disorders. The company is engaged in clinical research to address conditions related to hormonal imbalances, particularly those affecting the central nervous system. It develops synthetic compounds for therapeutic use in underserved medical areas. The company is headquartered in Solna, Sweden, and its shares are listed on the OMXSTO.
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
ASAP
Country
🇸🇪 Sweden